ABVC BioPharma, Inc. (ECOC) Gross profit 2016–2025
ABVC BioPharma, Inc. (ECOC) annual gross profit history from SEC filings — each fiscal year as reported.
$508,826FY2025 · since FY2016: $2,839 → $508,826
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $508,826 | +440.1% |
| FY2024 | -$149,607 | -121.9% |
| FY2023 | $683,368 | +94.9% |
| FY2022 | $350,711 | -24.5% |
| FY2021 | $464,329 | -31.9% |
| FY2020 | $681,582 | +482.2% |
| FY2019 | -$178,324 | — |
| FY2017 | -$32 | -101.1% |
| FY2016 | $2,839 | — |
Source: SEC XBRL filings · For reference only · Not investment advice